A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)
Active, not recruiting · Not applicable · NCT06948773
Conditions: Primary Open Angle Glaucoma, Cataract
At a glance
- Research payments reported, 2025
- $1,500
- U.S. investigators named
- 0
- Sites paid
- 0
- Planned or actual enrollment
- 25
About the trial
- Sponsor
- Sight Sciences, Inc.
- Tested
- Helix Surgical System (device)
- Dates
- Started 2025-05-21; completion 2026-09-30
- Results posted
- Not yet
A study to assess the safety of the Helix Surgical System in cataract surgery and to gain early evidence of its effectiveness in lowering intraocular pressure (IOP) in subjects with mild to moderate primary open-angle glaucoma (POAG) and cataracts.
From ClinicalTrials.gov, last updated 2026-07-07. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Sight Sciences, Inc. reported $1,500 in research payments for this study in 2025 (1 payments).
Products named: Sion Surgical Instrument, Omni Surgical System
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
Sites paid to run it
- $1,500
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.